Characterization of new topical ketoprofen formulations prepared by drug entrapment in solid lipid matrices

Journal of Pharmaceutical Sciences

Volumn 100, Issue 11, 2011, Pages 4783-4789

  Argemí, Anna ^a   Domingo, Concepción ^b   Sampaio de Sousa, Ana Raquel ^c   M Duarte, Catarina M ^c,d   García gonzález, Carlos A ^b   Saurina, Javier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

^c INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^d INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

Controlled release; Diffusion cell; HPLC UV; In vitro models; Ketoprofen determination; Kinetics; Microencapsulation; Solid lipid particles

Indexed keywords

CARBON DIOXIDE; KETOPROFEN; SOLID LIPID NANOPARTICLE; TITANIUM DIOXIDE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; HYDROPHOBICITY; LIMIT OF DETECTION; LIPOPHILICITY; NONHUMAN; PH;

EID: 80053254776     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22684     Document Type: Article

References (40)

1. Arida AI, Al-Tabakha MM. 2007. Encapsulation of ketoprofen for controlled drug release. Eur J Pharm Biopharm 66:48-54.
2. Benson HAE. 2005. Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Delivery 2:23-33
3. Bos JD, Meinardi MM. 2000. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9:165-169.
4. Puglia C, Blasi P, Rizza L, Schoubben A, Bonina F, Rossi C, Ricci M. 2008. Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation. Int J Pharm 357:295-304.
5. Sakeena MHF, Muthanna FA, Ghassan ZA, Kanakal MM, Elrashid SM, Munavvar AS, Azmin MN. 2010. Formulation and in vitro evaluation of ketoprofen in palm oil esters nanoemulsion for topical delivery. J Oleo Sci 59:223-228.
6. Wissing SA, Müller RH. 2002. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Controlled Release 81:225-233.
7. zur Mühlen A, Schwarz C, Mehnert W. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism. Eur J Pharm Biopharm 45:149-155.
8. Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. 2000. Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 49:211-218.
9. Maia CS, Mehnert W, Schäfer-Korting M. 2000. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 196:165-167.
10. Müller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery-Review of the state of the art. Eur J Pharm Biopharm 50:161-177.
11. Scalia S, Mezzenaa M. 2009. Incorporation of quercetin in lipid microparticles: Effect on photo- and chemical-stability. J Pharm Biomed Anal 49:90-94.
12. Jannin V, Musakhanian J, Marchaud D. 2008. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Delivery Rev 60:734-746.
13. García-González CA, Sampaio de Sousa AR, Argemí A, López Periago A, Saurina J, Duarte CMM, Domingo C. 2009. Production of hybrid lipid-based particles loaded with inorganic nanoparticles and active compounds for prolonged topical release. Int J Pharm 382:296-304.
14. García-González CA, Argemí A, Sampaio de Sousa AR, Duarte CMM, Saurina J, Domingo C. 2010. Encapsulation efficiency of solid lipid hybrid particles prepared using the PGSS® technique and loaded with different polarity active agents. J Supercrit Fluids 54:342-347.
15. Pasquali I, Bettini R. 2008. Are pharmaceutics really going supercritical? Int J Pharm 364:176-187.
16. Temelli F. 2009. Perspectives on supercritical fluid processing of fats and oils. J Supercrit Fluids 47:583-590.
17. Sampaio de Sousa AR, Simplício AL, de Sousa HC, Duarte CMM. 2007. Preparation of glyceryl monostearate-based particles by PGSS®: Application to caffeine. J Supercrit Fluids 43:120-125.
18. 2 as solvent and antisolvent. Powder Technol 142:13-22.
19. 2 applications in the processing of polymers. Ind Eng Chem Res 42:6431-6456.
20. Kazarian SG, Martirosyan GG. 2002. Spectroscopy of polymer/drug formulations processed with supercritical fluids: in situ ATR-IR and Raman study of impregnation of ibuprofen into PVP. Int J Pharm 232:81-90.
21. Tojo K. 1987. Design and calibration of in vitro permeation apparatus. In: Chien YW, Ed. Transdermal controlled systemic medications. New York: Marcel Dekker; pp. 127-158.
22. Frantz SW, 1990. Instrumentation and methodology for in vitro skin diffusion cells in methodology for skin absorption. In: Kemppainen BW, Reifenrath WG Eds. Methods for skin absorption. Florida: CRC Press; pp. 35-59.
23. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. 2001. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52:103-112.
24. Esposito E, Bortolotti F, Menegatti E, Cortesi R, 2003. Amphiphilic association systems for amphotericin B delivery. Int J Pharm 260:249-260.
25. Gallagher SJ, Trottet L, Carter TP, Heard CM, 2003. Effects of membrane type and liquid/liquid phase boundary on in vitro release of ketoprofen from gel formulations. J Drug Targ 11:373-379.
26. Martin MJ, Pablos F, Gonzalez AG. 1999. Simultaneous determination of caffeine and non-steroidal anti-inflammatory drugs in pharmaceutical formulations and blood plasma by reversed-phase HPLC from linear gradient elution. Talanta 49:453-459.
27. Tettey-Amlalo RNO, Kanfer I. 2009. Rapid UPLC-MS/MS method for the determination of ketoprofen in human dermal microdialysis samples. J Pharm Biomed Anal 50:580-586.
28. Dvorák J, Hájková R, Matysová L, Nováková L, Koupparis MA, Solich P. 2004. Simultaneous HPLC determination of ketoprofen and its degradation products in the presence of preservatives in pharmaceuticals. J Pharm Biomed Anal 36:625-629.
29. Escuder-Gilabert L, Martin-Biosca Y, Sagrado S, Villanueva-Camanas RM, Medina-Hernandez MJ. 2002. Quality control of pharmaceuticals containing non-steroidal anti-inflammatory drugs by micellar liquid chromatography. Chromatographia 55:283-288.
30. Labbozzetta S, Valvo L, Bertocchi P, Alimonti S, Gaudiano MC, Manna L. 2009. Focused microwave-assisted extraction and LC determination of ketoprofen in the presence of preservatives in a pharmaceutical cream formulation. Chromatographia 69:365-368.
31. Blanco M, Gonzalez JM, Torras E, Valverde I. 2003. Enantiomeric purity determination of ketoprofen by capillary electrophoresis: development and validation of the method. Anal Bioanal Chem 375:157-163.
32. Donato MG, Baeyens W, Van den Bossche W, Sandra P. 1994. The determination of nonsteroidal antiinflammatory drugs in pharmaceuticals by capillary zone electrophoresis and micellar electrokinetic capillary chromatography. J Pharm Biomed Anal 12:21-26.
33. Al-Kindy SMZ, Al-Harasi Z, Suliman FEO, Al-Hamadi A, Pillay A. 2009. Terbium sensitized luminescence for the determination of ketoprofen in pharmaceutical formulations. J Flourescence 249-255.
34. Ozlu C, Basan H, Satana E, Ertas N, Goger NG, 2005. Quantitative determination of ketoprofen in gels and ampules by using flow-injection UV spectrophotometry and HPLC. J Pharm Biomed Anal 39:606-611.
35. Hadgraft J, Walters KA, Wotton PK. 1986. Facilitated percutaneous absorption: a comparison and evaluation of two in vitro models. Int J Pharm 32:257-263.
36. Liebenberg W, Engelbrecht E, Wessels A, Devarakonda B, Yang W, de Villiers M. 2004. A comparative study of the release of active ingredients from semisolid cosmeceuticals measured with Franz, enhancer or flow-through cell diffusion apparatus. J Food Drug Anal 12;19-28.
37. Liu X, Hefesha H, Scriba G, Fahr A, 2008. Retention behavior of neutral and positively and negatively charged solutes on an immobilized-artificial-membrane (IAM) stationary phase. Helv Chim Acta 91:1505-1512.
38. Bronaugh RL, Maibach HI. 1985. Percutaneous absorption: mechanisms-methodology-drug delivery, Part 3. Vol. 6. New York: Marcel Dekker.
39. Higuchi WI. 1962. Analysis of data on the medicament release from ointments. J Pharm Sci 51:802-804.
40. Pardeike J, Hommoss A, Müller RH. 2009. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366:170-184.